Recent News for SPRB - Spruce Biosciences, Inc.

Date Title
Mar 2 Spruce Biosciences to Announce Phase 1 and 2 Data of Tildacerfont at Endocrine Society’s 2021 Annual Meeting
Feb 17 Spruce Biosciences to Participate in Upcoming Investor Conferences
Jan 12 What Type Of Shareholders Make Up Spruce Biosciences, Inc.'s (NASDAQ:SPRB) Share Registry?
Jan 6 Spruce Biosciences outlines milestones for 2021
Jan 6 Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
Dec 17 Spruce Biosciences Added to Russell 2000®, 3000® and Microcap® Indexes
Nov 18 Spruce Biosciences EPS misses by $6.26
Nov 18 Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 17 The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
Nov 4 Spruce Biosciences to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
Nov 3 Benzinga's Top Upgrades, Downgrades For November 3, 2020
Nov 1 The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Oct 19 Novo Holdings reports 21.5% stake in Spruce Biosciences
Oct 16 Airbus Is Struggling. And a Contract to Build a Mars Spacecraft Can’t Lift the Earthbound Gloom.
Oct 15 The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
Oct 9 Spruce Biosciences prices upsized IPO at $15, raising $90M
Oct 6 Spruce Biosciences Proposes $75 Million IPO Terms
Oct 5 Spruce Biosciences sets IPO terms
Back to the Main SPRB Page...